Brief: Synlab Participates In Largest Ever Multinational Study On Cholesterol
17/07/2023 06:32
July 17 (Reuters) - SYNLAB AG SYAB.DE :
* PLAYS KEY ROLE IN LARGEST EVER MULTINATIONAL STUDY ON
CHOLESTEROL
* PARTICIPATES IN LARGEST EVER MULTI-NATIONAL STUDY TO
DETERMINE
VARIATIONS IN LIPID PROFILES TO IMPROVE UNDERSTANDING OF
CARDIOVASCULAR RISK IN DIFFERENT COUNTRIES
* SIGNIFICANT DIFFERENCES IN TOTAL CHOLESTEROL LEVELS ACROSS
17
COUNTRIES PROVIDE OPPORTUNITIES FOR TAILORED PREVENTION
Source text for Eikon: ID:nEQ5DjcT9a
Further company coverage: SYAB.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Synlab AG
See all newsUK's NHS says hackers have published data stolen in ransomware attack (updated)
Brief: Synlab Says Cybersecurity Incident At Synnovis In UK
Diagnostics provider Synlab signs delisting agreement with Ephios
Brief: Ephios Bidco To Make Public Delisting Acquisition Offer To Shareholders Of Synlab
Brief: Synlab Continues To Expect AEBITDA Margin To Improve From Its Low Point in 2023